Is LITHI - PHARMA still active?

Yes, LITHI - PHARMA is currently active.

What does LITHI - PHARMA do?

LITHI - PHARMA's registered main activities are Activities of fitness centres, Activities of holding companies, Day spa, sauna and steam bath activities, Tanning salons, and Services related to well-being and physical comfort provided in thalassotherapy establishments, spas, Turkish baths, saunas, steam baths, massage parlours, etc.. It is also registered for 3 additional activities.

Where is LITHI - PHARMA registered?

LITHI - PHARMA's registered address is Zomerloosstraat 33 box A, 8470 Gistel, Belgium.

Did LITHI - PHARMA make a profit or a loss?

LITHI - PHARMA's most recently filed annual accounts (fiscal year ending 30 Jun 2025) reported a loss of €223,557.

When did LITHI - PHARMA last file annual accounts?

LITHI - PHARMA's most recently filed annual accounts cover the fiscal year ending 30 Jun 2025.

Is LITHI - PHARMA B Corp certified?

We have no B Corp certification on file for LITHI - PHARMA.

Does LITHI - PHARMA hold Fairtrade certification?

No, LITHI - PHARMA does not currently hold Fairtrade certification.

LITHI - PHARMA

Q: What is LITHI - PHARMA's legal form?

Naamloze vennootschap (NV) / Société anonyme (SA).

Q: When was LITHI - PHARMA founded?

LITHI - PHARMA was founded on 06 Jan 1993, making it 33 years old.

BE 0449.135.041

Copied!

NV/SA

Status

Active

Founded

06 Jan 1993

Size

Micro

Age

33 yrs

Main activity

Activities of fitness centres

Activities

8 activities

Activities of fitness centresActivities of holding companiesDay spa, sauna and steam bath activitiesTanning salonsServices related to well-being and physical comfort provided in thalassotherapy establishments, spas, Turkish baths, saunas, steam baths, massage parlours, etc.Business and other management consultancy activitiesRental and operating of own or leased residential real estate, except social housingOther business support service activities n.e.c.

Financials

Profit / Loss2025

−€224K<-1000%

Equity2025

€553K-28.8%

Cash2025

€24.8K+968.1%

2025	2024	2023	2022
-€223,557<-1000%	-€18,359-115.3%	€119,769+324%	€28,249
€553,324-28.8%	€776,881-2.3%	€795,240+17.7%	€675,471
€923,223-10.4%	€1,029,929-20.2%	€1,291,281-13.1%	€1,485,936
€24,844+968.1%	€2,326-90.1%	€23,438+180.7%	€8,349

Frequently asked questions

01What is LITHI - PHARMA's official registered name?

LITHI - PHARMA.

02What is LITHI - PHARMA's enterprise number (VAT number)?

BE 0449.135.041.

03What is LITHI - PHARMA's legal form?

Naamloze vennootschap (NV) / Société anonyme (SA).

04When was LITHI - PHARMA founded?

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

	2025	2024	2023	2022
Income statement
	€149,752+263.7%	€41,181-79.9%	€204,719+64.9%	€124,145
	€71,304+566%	€10,706+146.1%	€4,350-99.6%	€1,002,442
	-€252,373<-1000%	-€13,076-108.7%	€150,179+870.3%	-€19,495
	-€223,557<-1000%	-€18,359-115.3%	€119,769+324%	€28,249
	€8,793+155.5%	€3,442-32.3%	€5,082+98.7%	€2,558
Profitability
	-40.4%<-1000%	-2.4%-115.7%	15.1%+260.1%	4.2%
	-13.9%<-1000%	-0.9%-117.6%	5.3%+335.7%	1.2%
Solvency
	€1,610,593-18.4%	€1,974,369-12.7%	€2,262,080-2.7%	€2,324,531
	€1,169,575+3.1%	€1,133,936-2.9%	€1,168,339-14.8%	€1,371,325
	€325,1510%	€325,1510%	€325,1510%	€325,151
	€553,324-28.8%	€776,881-2.3%	€795,240+17.7%	€675,471
	34.4%-12.7%	39.3%+11.9%	35.2%+21%	29.1%
	€577,705-8.2%	€629,510-24.1%	€829,981-7%	€892,336
	1.04+28.9%	0.81-22.4%	1.04-21%	1.32
	€923,223-10.4%	€1,029,929-20.2%	€1,291,281-13.1%	€1,485,936
	1.67+25.9%	1.33-18.3%	1.62-26.2%	2.20
Liquidity
	€24,844+968.1%	€2,326-90.1%	€23,438+180.7%	€8,349
	€34,097>1000%	€4-99.7%	€1,629-94.8%	€31,247
	€70,156>1000%	€1,516+22.1%	€1,242-95.7%	€28,970
	€344,701-13.7%	€399,520-12.7%	€457,411-22.5%	€590,279
	0.26-79.4%	1.28-20.7%	1.62+55%	1.04
	-€229,651-299.9%	€114,863-62.6%	€307,290+818.5%	€33,455
Profit appropriation
	€401,480-21%	€508,287-4.5%	€532,006+8.3%	€491,372
	-€48,157-170.2%	€68,594+8.5%	€63,235+497.7%	-€15,901